Document is current
Any future updates will be listed below
-
Authors
Mallone, Roberto https://orcid.org/0000-0002-9846-8861
Bandini, Aude https://orcid.org/0000-0002-7011-261X
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-25-CE15-2811)
Leona M. and Harry B. Helmsley Charitable Trust (2412-07951)
Social Sciences and Humanities Research Council of Canada (430-2025-00617)
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 2 December 2025
First Online: 23 January 2026
Funding
: Work in RM’s laboratory is supported by the Leona M. & Harry B. Helmsley Charitable Trust (grant 2412-07951), an EU H2023 grant 101137457 (ENT1DEP) and the Agence Nationale de la Recherche (grant ANR-25-CE15-2811). This work has received support under the investment programme ‘France 2030’ launched by the French Government and implemented by the University Paris Cité as part of its programme ‘Initiative d’excellence’ (IdEX, grant ANR-18-IDEX-0001), in which is included the InIdEX project DiabetEX. AB’s research is supported by the Social Sciences and Humanities Research Council of Canada (grant 430-2025-00617).
: RM serves on advisory panels and speakers’ bureaus for Amarna Therapeutics and Sanofi; financial compensation for these activities has been received by the AP-HP Foundation. RM serves on the advisory panel of and owns stocks in Endotope Biosciences. RM is a member of the Editorial Board of Diabetologia .
: Both authors conceived the letter, drafted the text and approved the final version.
